ArticleAnnals of coloproctology2013

A Phase II Study of Additional Four-Week Chemotherapy With Capecitabine During the Resting Periods After Six-Week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.

Kyung Ha Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.